FDA Inspection
Hunterdon Medical Center Blood BankHunterdon Medical Center Blood Bank – FDA Inspection, Jul 25, 2013
Record Details
This FDA Inspection record concerns Hunterdon Medical Center Blood Bank, with an inspection on July 25, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 25, 2013
- Product Type
- Biologics
View Company Profile
ID · 7225febd-aa83-49f8-b947-8aa832d56eb0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 841720
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hunterdon Medical Center Blood Bank
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2025 | Not classified | New Jersey District Office | |
| September 20, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 5, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 11, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 18, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Hunterdon Medical Center Blood Bank
- FDA Inspection 1261856 - 2025-02-14
- FDA Inspection 1103401 - 2019-09-20
- FDA Inspection 1008026 - 2017-04-05
- FDA Inspection 913703 - 2015-02-11
- FDA Inspection 730681 - 2011-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.